Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Tegning af konvertible lån fuldført 21. marts 2024Meddelelse nr. 08 Bestyrelsen i Pharma Equity Group besluttede den 7. februar 2024 at udstede konvertible lån i overensstemmelse med...
-
Completion of subscription of convertible loans March 21, 2024Company Announcement no. 08 On 7 February 2024, the Board of Directors of Pharma Equity Group decided to issue...
-
Correction: Adding Annual Report in xhtml-file zip-format Pharma Equity Group A/S - Årsrapport 2023 Dato: 20. marts 2024 Årets meddelelse nr.: 07 Pharma Equity Group A/S - Årsrapport...
-
Correction: Adding Annual Report in xhtml-file zip-format Pharma Equity Group A/S - Annual Report 2023 Date: March 20, 2024Announcement of the Year No.: 7 Pharma Equity Group A/S - Annual...
-
Pharma Equity Group A/S - Årsrapport 2023 Dato: 20. marts 2024 Årets meddelelse nr.: 07 Pharma Equity Group A/S - Årsrapport 2023 - året i hovedtræk Bestyrelsen for Pharma Equity Group A/S har dags...
-
Pharma Equity Group A/S - Annual Report 2023 Date: March 20, 2024Announcement of the Year No.: 7 Pharma Equity Group A/S - Annual report 2023 - main features of the year Today, the Board of...
-
Pharma Equity Groups datterselskab (Reponex Pharmaceuticals A/S) har modtaget meddelelse fra Det Europæiske Patentkontor (EPO) om beslutningen om at tildele deres patent for lægemiddelsammensætninger...
-
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for...
-
7. februar 2024 Selskabsmeddelelse nr. 05 Tegning af konvertible lån fuldført Bestyrelsen i Pharma Equity Group besluttede den 7. februar 2024 at udstede konvertible lån i overensstemmelse...
-
7 February 2024 Company Announcement No. 05 Completion of subscription of convertible loans On 7 February 2024 the Board of Directors in Pharma Equity Group decided to issue convertible...